Dr. Agarwal's Eye Hospital Limited has filed its quarterly compliance certificate with BSE Limited for the period January-March 2026, fulfilling regulatory obligations under SEBI (Depositories and Participants) Regulations, 2018. The submission was made on April 07, 2026, by Company Secretary and Compliance Officer Meenakshi Jayaraman.

Regulatory Compliance Submission

The compliance certificate was submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The certificate covers the company's operations for the quarter ending March 31, 2026, specifically addressing dematerialisation and rematerialisation processes.

Registrar and Transfer Agent Confirmation

Integrated Registry Management Services Private Limited, serving as the company's Registrar and Transfer Agents, provided the compliance confirmation on April 03, 2026. The agency confirmed that monthly reports on dematerialised and rematerialised shares for the January-March 2026 quarter were duly sent to respective stock exchanges.

The registrar confirmed compliance with three key regulatory requirements:

• Shares received for dematerialisation have been listed on stock exchanges where earlier issued shares were listed
• Mutilated and cancelled certificates were properly verified and substituted in records within the prescribed 15-day timeframe
• Details of shares dematerialised or rematerialised during the period were furnished to all relevant stock exchanges

Corporate Communication

The formal communication was addressed to BSE Limited's Corporate Relationship Department at Phiroze Jeejeebhai Towers, Dalal Street, Mumbai. The submission includes the digitally signed certificate from the company's authorized signatory, ensuring proper authentication and regulatory compliance.

Integrated Registry Management Services Private Limited, headquartered in Chennai, operates from Kences Towers on North Usman Road and maintains its registered office at the same location. The agency emphasized the importance of nominee appointments as a shareholder right in its communication.

Dr. Agarwal's Eye Hospital Limited has announced the assignment of credit ratings by ICRA Limited for its debt facilities. The rating agency communicated its decision to the company on February 23, 2026, covering multiple banking facilities totaling ₹140.00 crore.

Credit Rating Details

ICRA Limited has assigned specific ratings to the company's banking arrangements with detailed facility-wise breakdowns. The ratings reflect the agency's assessment of the company's creditworthiness and repayment capacity across different debt instruments.

Rating Significance

The ICRA AA- (Stable) rating indicates high credit quality with very low credit risk. The stable outlook suggests that the rating is unlikely to change in the near term. For short-term facilities, the ICRA A1+ rating represents the highest degree of safety regarding timely payment of financial obligations.

Regulatory Compliance

The company has disclosed this credit rating assignment to BSE Limited in accordance with Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Meenakshi Jayaraman signed the disclosure document on February 23, 2026.

Banking Relationship

The primary facility covered under this rating assignment is with Axis Bank Limited, which has extended an ₹85.80 crore long-term loan to the company. The unallocated limits of ₹54.20 crore provide additional financial flexibility for the company's operational and strategic requirements.